Literature DB >> 18492610

Synthesis, induced-fit docking investigations, and in vitro aldose reductase inhibitory activity of non-carboxylic acid containing 2,4-thiazolidinedione derivatives.

Rosanna Maccari1, Rosaria Ottanà, Rosella Ciurleo, Dietmar Rakowitz, Barbara Matuszczak, Christian Laggner, Thierry Langer.   

Abstract

In continuation of our studies, we here report a series of non-carboxylic acid containing 2,4-thiazolidinedione derivatives, analogues of previously synthesized carboxylic acids which we had found to be very active in vitro aldose reductase (ALR2) inhibitors. Although the replacement of the carboxylic group with the carboxamide or N-hydroxycarboxamide one decreased the in vitro ALR2 inhibitory effect, this led to the identification of mainly non-ionized derivatives with micromolar ALR2 affinity. The 5-arylidene moiety deeply influenced the activity of these 2,4-thiazolidinediones. Our induced-fit docking studies suggested that 5-(4-hydroxybenzylidene)-substituted derivatives may bind the polar recognition region of the ALR2 active site by means of the deprotonated phenol group, while their acetic chain and carbonyl group at position 2 of the thiazolidinedione ring form a tight net of hydrogen bonds with amino acid residues of the lipophilic specificity pocket of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18492610     DOI: 10.1016/j.bmc.2008.04.072

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  7 in total

1.  Synthesis and Hypoglycemic and Anti-inflammatory Activity Screening of Novel Substituted 5-[Morpholino(Phenyl)Methyl]-Thiazolidine-2,4-Diones and Their Molecular Docking Studies.

Authors:  Srikanth Kumar Karumanchi; Lakshmana Rao Atmakuri; V Basaveswara Rao Mandava; Srikala Rajala
Journal:  Turk J Pharm Sci       Date:  2019-11-11

2.  Investigation of synergistic mechanism and identification of interaction site of aldose reductase with the combination of gigantol and syringic acid for prevention of diabetic cataract.

Authors:  Jie Wu; Xue Li; Hua Fang; Yanqun Yi; Dan Chen; Yan Long; Xinxin Gao; Xiaoyong Wei; C-Y Oliver Chen
Journal:  BMC Complement Altern Med       Date:  2016-08-12       Impact factor: 3.659

3.  Novel Benzylidene Thiazolidinedione Derivatives as Partial PPARγ Agonists and their Antidiabetic Effects on Type 2 Diabetes.

Authors:  Sabina Yasmin; Fabio Capone; Antonio Laghezza; Fabrizio Dal Piaz; Fulvio Loiodice; Viswanathan Vijayan; Velmurugan Devadasan; Susanta K Mondal; Özlem Atlı; Merve Baysal; Ashok K Pattnaik; Venkatesan Jayaprakash; Antonio Lavecchia
Journal:  Sci Rep       Date:  2017-10-31       Impact factor: 4.379

Review 4.  5-Ene-4-thiazolidinones - An efficient tool in medicinal chemistry.

Authors:  Danylo Kaminskyy; Anna Kryshchyshyn; Roman Lesyk
Journal:  Eur J Med Chem       Date:  2017-09-20       Impact factor: 6.514

5.  Syringic Acid Extracted from Herba dendrobii Prevents Diabetic Cataract Pathogenesis by Inhibiting Aldose Reductase Activity.

Authors:  Xiaoyong Wei; Dan Chen; Yanchun Yi; Hui Qi; Xinxin Gao; Hua Fang; Qiong Gu; Ling Wang; Lianquan Gu
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-29       Impact factor: 2.629

6.  Design, synthesis, biological evaluation and molecular docking studies of novel 3-substituted-5-[(indol-3-yl)methylene]-thiazolidine-2,4-dione derivatives.

Authors:  K Srikanth Kumar; A Lakshmana Rao; M V Basaveswara Rao
Journal:  Heliyon       Date:  2018-09-20

7.  Non-acidic bifunctional benzothiazole-based thiazolidinones with antimicrobial and aldose reductase inhibitory activity as a promising therapeutic strategy for sepsis.

Authors:  Antonios Kousaxidis; Lucia Kovacikova; Ioannis Nicolaou; Milan Stefek; Athina Geronikaki
Journal:  Med Chem Res       Date:  2021-08-04       Impact factor: 2.351

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.